Italy

 

DocPlanner flying towards Unicorn status

DocPlanner, the online booking and rating platform rival to Doctolib, has just closed a Series E funding round for €80m, but the company says it has "some way to go" to unicorn status. 

How are the big diagnostic labs doing?

We examine a feast of data, the 2018 results, from Cerba, Synlab and Unilabs and contrast them with Sonic and Eurofins. What do they tell us about their performance across routine lab testing, acquisitions and diversification?

San Donato set to move into Russia

Italy's largest hospital group is "in the middle of acquiring" a hospital-based asset in the east of Russia - its first acquisition in the country.

Selling whole genome sequencing to consumers

Javier Echevarria, CEO, Europe and LatAm of Veritas International (VI) has one of the most interesting challenges in marketing - how do you persuade wealthy consumers to spend around $2,000 on predictive whole genome sequencing (WGS)?  He has a broad canvas - his remit is to sell across LatAm, UAE, Europe and Japan.

FREE BLOG Is Acute’s little brother Rehab coming of age?

HBI has just finished a deep dive into the rehabilitation sector. This small, fragmented, poor relative of acute care is often ignored by operators. A perception of low margins and a reluctance among acute hospitals to refer on to rehab cannot be helping. But things are changing, and new markets are opening up.

IPOs no-show as market slows

Two of Europe’s biggest healthcare companies which were widely expected to IPO imminently are now, we hear, ruling out this year. Why the delay – and what does this tell us about the state of a slowing market? HBI speaks to an operator CEO and investment banking sources.

San Donato looks set to IPO

Despite a generally weak hospital IPO market in Europe, Italy's largest hospital operator by revenue, Gruppo San Donato, looks set to list - perhaps prompted by the strong start the country's stock market has made to 2019.

Find Us